Logo image of LFMDP

LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis

USA - NASDAQ:LFMDP - US53216B2034

23.7501 USD
-0.25 (-1.04%)
Last: 10/16/2025, 8:00:03 PM
Fundamental Rating

3

Taking everything into account, LFMDP scores 3 out of 10 in our fundamental rating. LFMDP was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMDP have multiple concerns. LFMDP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LFMDP had negative earnings in the past year.
In the past year LFMDP had a positive cash flow from operations.
In the past 5 years LFMDP always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LFMDP reported negative operating cash flow in multiple years.
LFMDP Yearly Net Income VS EBIT VS OCF VS FCFLFMDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

LFMDP has a Return On Assets (-12.28%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -12.28%
ROE N/A
ROIC N/A
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMDP Yearly ROA, ROE, ROICLFMDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

With an excellent Gross Margin value of 87.57%, LFMDP belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
In the last couple of years the Gross Margin of LFMDP has grown nicely.
LFMDP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
LFMDP Yearly Profit, Operating, Gross MarginsLFMDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMDP has more shares outstanding
The number of shares outstanding for LFMDP has been increased compared to 5 years ago.
LFMDP has a better debt/assets ratio than last year.
LFMDP Yearly Shares OutstandingLFMDP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LFMDP Yearly Total Debt VS Total AssetsLFMDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

LFMDP has an Altman-Z score of 6.99. This indicates that LFMDP is financially healthy and has little risk of bankruptcy at the moment.
LFMDP's Altman-Z score of 6.99 is amongst the best of the industry. LFMDP outperforms 85.71% of its industry peers.
The Debt to FCF ratio of LFMDP is 2.31, which is a good value as it means it would take LFMDP, 2.31 years of fcf income to pay off all of its debts.
LFMDP has a Debt to FCF ratio of 2.31. This is in the better half of the industry: LFMDP outperforms 74.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.31
Altman-Z 6.99
ROIC/WACCN/A
WACC10.51%
LFMDP Yearly LT Debt VS Equity VS FCFLFMDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

LFMDP has a Current Ratio of 0.77. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.77, LFMDP is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
A Quick Ratio of 0.72 indicates that LFMDP may have some problems paying its short term obligations.
The Quick ratio of LFMDP (0.72) is worse than 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.72
LFMDP Yearly Current Assets VS Current LiabilitesLFMDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.00% over the past year.
Looking at the last year, LFMDP shows a very strong growth in Revenue. The Revenue has grown by 37.74%.
Measured over the past years, LFMDP shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%

3.2 Future

Based on estimates for the next years, LFMDP will show a very strong growth in Earnings Per Share. The EPS will grow by 40.83% on average per year.
Based on estimates for the next years, LFMDP will show a quite strong growth in Revenue. The Revenue will grow by 19.29% on average per year.
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5YN/A
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LFMDP Yearly Revenue VS EstimatesLFMDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
LFMDP Yearly EPS VS EstimatesLFMDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LFMDP. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 99.79, the valuation of LFMDP can be described as expensive.
LFMDP's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of LFMDP to the average of the S&P500 Index (22.94), we can say LFMDP is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 99.79
LFMDP Price Earnings VS Forward Price EarningsLFMDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

LFMDP's Enterprise Value to EBITDA is on the same level as the industry average.
LFMDP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 159.66
EV/EBITDA 122.65
LFMDP Per share dataLFMDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

LFMDP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LFMDP's earnings are expected to grow with 40.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.23%
EPS Next 3Y40.83%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.34%, LFMDP is a good candidate for dividend investing.
LFMDP's Dividend Yield is rather good when compared to the industry average which is at 4.96. LFMDP pays more dividend than 100.00% of the companies in the same industry.
LFMDP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 9.34%

5.2 History

LFMDP has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
LFMDP Yearly Dividends per shareLFMDP Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

LFMDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-34.38%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
LFMDP Yearly Income VS Free CF VS DividendLFMDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

LIFEMD INC - LFMD 8 7/8 PERP

NASDAQ:LFMDP (10/16/2025, 8:00:03 PM)

23.7501

-0.25 (-1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners53.98%
Inst Owner ChangeN/A
Ins Owners18.82%
Ins Owner ChangeN/A
Market Cap1.07B
Analysts81.33
Price Target48.91 (105.94%)
Short Float %0%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield 9.34%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years1
Ex-Date10-03 2025-10-03 (0.5546875)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)74.43%
PT rev (3m)129.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-89.82%
EPS NY rev (3m)-859.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 99.79
P/S 4.36
P/FCF 159.66
P/OCF 54.92
P/B N/A
P/tB N/A
EV/EBITDA 122.65
EPS(TTM)-0.21
EYN/A
EPS(NY)0.24
Fwd EY1%
FCF(TTM)0.15
FCFY0.63%
OCF(TTM)0.43
OCFY1.82%
SpS5.45
BVpS-0.04
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.57%
FCFM 2.73%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.31
Debt/EBITDA 0.41
Cap/Depr 120.74%
Cap/Sales 5.2%
Interest Coverage N/A
Cash Conversion 227.76%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.72
Altman-Z 6.99
F-Score5
WACC10.51%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5YN/A
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.54%
EBIT Next 3Y69.78%
EBIT Next 5YN/A
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%